A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
British Journal of Haematology · 16.11.2026
DOI: 10.1111/bjh.70940 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 16.11.2026. Verfasst von Victor Tellez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Berenson Cancer Center, West Hollywood, California, USA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: mQOL.
Abstract (Originalsprache)
Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility between visits. This creates a critical gap in care, as evolving symptoms and treatment‐related toxicities frequently occur outside scheduled encounters and may remain unrecognized. A single‐centre pilot study evaluated the feasibility and clinical utility of a short message service (SMS)‐based remote monitoring platform, assessing 8 symptoms and 10 QoL domains for 58 MM patients over 90 days. End‐points included feasibility and engagement measured using completion rates, time burden and identification of clinically actionable events. A total of 1604 assessments were delivered, with an overall completion rate of 85.5%, and 72.4% of participants achieving >80% completion rate. Median completion time was 1.80 min. During the 90‐day study period, 215 predefined alerts were generated, of which 101 (47.0%) prompted clinical intervention within 48 h, frequently occurring outside routine clinic visits. SMS‐based remote monitoring demonstrated high feasibility, sustained engagement and minimal patient burden. This platform enabled real‐time identification of symptoms and facilitated rapid follow‐up by clinicians, supporting its potential for remote therapeutic monitoring rather than a passive data collection tool.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Berenson Cancer Center, West Hollywood, California, USA.
- Institute for Myeloma & Bone Cancer Research, West Hollywood, California, USA.
- mQOL, San Jose, California, USA.
ORCID-Profile: Anirvin Bommaraju, Jamie Cheung, Randall Noval, James R Berenson
Förderung
- mQOL
Zitieren
APA
Tellez, V., Bommaraju, A., Cheung, J., Swift, R., Moore, J., Sayad, P., Pezzullo, F., Gette, A., Wright, A., Hall, J., Noval, R., Morrison, B., & Berenson, J. R. (2026). A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study. British Journal of Haematology. https://doi.org/10.1111/bjh.70940
Vancouver
Tellez V, Bommaraju A, Cheung J, Swift R, Moore J, Sayad P, et al. A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study. British Journal of Haematology. 2026. doi:10.1111/bjh.70940
BibTeX
@article{Tellez2026,
author = {Tellez, Victor and Bommaraju, Anirvin and Cheung, Jamie and Swift, Regina and Moore, Jonathan and Sayad, Pierre and Pezzullo, Frank and Gette, Aaron and Wright, Alex and Hall, Jon and Noval, Randall and Morrison, Blake and Berenson, James R},
title = {A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70940}
}
EUVIMED